ribociclib
novartis
['natalee', 'kisqali', 'breast', 'in person']
great to attend #asco2023 in person!
so far, very interesting updated results from the phase iii natalee trial at asco 2023 - a broad approval in the lucrative hr+her2- breast cancer setting for kisqali may be on the horizon &amp; could push kisqali s sales close to the $1bn mark!
Healthcare Analyst at @Datamonitor_HC, Citeline. All views are my own.